Teva Pharmaceuticals Q4 2016 Earnings
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
Is Teva Pharmaceuticals Stock a Buy? | The Motley Fool
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
TEVA Pharmaceutical Sell-Off, is it Time to Buy, Sell or Hold? – PGM Capital
Teva Pharmaceuticals will pay $420 million in a federal case
Settling a post-buyout hangover, Allergan gives Teva a $700M remedy | Fierce Pharma
Why This Teva Pharmaceuticals Analyst Is Turning Bullish 'The Most Room To Re-Rate' | Markets Insider
Outgoing Moderna CMO Lands Seat on Teva Pharmaceuticals Board of Directors | BioSpace
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/LCGCPK3EYBF3PJZYOYFN26JDWQ.jpg "Teva buying Allergan, drops Mylan bid")
Teva buying Allergan, drops Mylan bid
Teva offers to buy Mylan in $40 billion deal | The Times of Israel
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
$40B deal: Teva offers to buy Mylan
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Faces Rocky Path to Recovery After Debt | Fortune
Teva Pharmaceuticals to Buy Allergan's Generics Business - The New York Times
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Should You Buy Teva Pharmaceutical Industries Ltd (TEVA) Stock Monday Morning?
Why You Should Still Buy Teva (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutics USA acquires three buildings for an R&D campus in West Chester - Philadelphia Business Journal
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
What's Next For Teva Pharmaceutical Stock After A 17% Fall In A Month?
Teva Pharmaceutical to buy Mexican Drugmaker
